Search

Christopher Upton

Examiner (ID: 3762, Phone: (571)272-1169 , Office: P/1778 )

Most Active Art Unit
1778
Art Unit(s)
1797, 1306, 1308, 1776, 1778, 1724
Total Applications
3146
Issued Applications
2580
Pending Applications
123
Abandoned Applications
451

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 13790741 [patent_doc_number] => 20190008909 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-10 [patent_title] => MEANS AND METHODS FOR AAV GENE THERAPY IN HUMANS [patent_app_type] => utility [patent_app_number] => 16/031906 [patent_app_country] => US [patent_app_date] => 2018-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9956 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16031906 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/031906
Means and methods for AAV gene therapy in humans Jul 9, 2018 Issued
Array ( [id] => 15160813 [patent_doc_number] => 10485879 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-26 [patent_title] => Plasma cell cytokine vehicle containing fusion proteins for targeted introduction of siRNA into cells and tissues [patent_app_type] => utility [patent_app_number] => 16/011263 [patent_app_country] => US [patent_app_date] => 2018-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13357 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16011263 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/011263
Plasma cell cytokine vehicle containing fusion proteins for targeted introduction of siRNA into cells and tissues Jun 17, 2018 Issued
Array ( [id] => 13522585 [patent_doc_number] => 20180312835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-01 [patent_title] => crRNA for detecting RSPO2 gene in body fluid with CRISPR-Cas13a specificity and applications thereof [patent_app_type] => utility [patent_app_number] => 16/010411 [patent_app_country] => US [patent_app_date] => 2018-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4186 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16010411 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/010411
crRNA for detecting RSPO2 gene in body fluid with CRISPR-Cas13a specificity and applications thereof Jun 15, 2018 Abandoned
Array ( [id] => 16468521 [patent_doc_number] => 20200370058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-26 [patent_title] => A HTP GENOMIC ENGINEERING PLATFORM FOR IMPROVING ESCHERICHIA COLI [patent_app_type] => utility [patent_app_number] => 16/620069 [patent_app_country] => US [patent_app_date] => 2018-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 94537 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16620069 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/620069
A HTP GENOMIC ENGINEERING PLATFORM FOR IMPROVING ESCHERICHIA COLI Jun 5, 2018 Abandoned
Array ( [id] => 13554755 [patent_doc_number] => 20180328925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-15 [patent_title] => MEMBRANE BOUND REPORTER MOLECULES AND THEIR USE IN CELL SORTING [patent_app_type] => utility [patent_app_number] => 15/975848 [patent_app_country] => US [patent_app_date] => 2018-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13426 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15975848 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/975848
Membrane bound reporter molecules and their use in cell sorting May 9, 2018 Issued
Array ( [id] => 13387049 [patent_doc_number] => 20180245066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-30 [patent_title] => sgRNA and knockout method of human RSPO2 gene targeted with CRISPR-Cas9 specificity and application thereof [patent_app_type] => utility [patent_app_number] => 15/961886 [patent_app_country] => US [patent_app_date] => 2018-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5920 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15961886 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/961886
sgRNA and knockout method of human RSPO2 gene targeted with CRISPR-Cas9 specificity and application thereof Apr 24, 2018 Abandoned
Array ( [id] => 13343651 [patent_doc_number] => 20180223365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-09 [patent_title] => METHOD FOR SCREENING CANDIDATE COMPOUNDS FOR PREVENTING AND/OR ATTENUATING SKIN AGING, AND/OR FOR HYDRATING THE SKIN [patent_app_type] => utility [patent_app_number] => 15/947005 [patent_app_country] => US [patent_app_date] => 2018-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6730 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15947005 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/947005
METHOD FOR SCREENING CANDIDATE COMPOUNDS FOR PREVENTING AND/OR ATTENUATING SKIN AGING, AND/OR FOR HYDRATING THE SKIN Apr 5, 2018 Abandoned
Array ( [id] => 19259018 [patent_doc_number] => 12019068 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-25 [patent_title] => Method for predicting therapeutic effect and/or recurrence monitoring in cancer patients [patent_app_type] => utility [patent_app_number] => 16/498895 [patent_app_country] => US [patent_app_date] => 2018-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4118 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498895 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/498895
Method for predicting therapeutic effect and/or recurrence monitoring in cancer patients Mar 29, 2018 Issued
Array ( [id] => 13987133 [patent_doc_number] => 20190062724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-28 [patent_title] => RNA TARGETING METHODS AND COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 15/937699 [patent_app_country] => US [patent_app_date] => 2018-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44170 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15937699 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/937699
RNA targeting methods and compositions Mar 26, 2018 Issued
Array ( [id] => 13329129 [patent_doc_number] => 20180216102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-02 [patent_title] => Methods for Obtaining Information from Single Cells Within Populations Using DNA Origami Nanostructures Without the Need for Single Cell Sorting [patent_app_type] => utility [patent_app_number] => 15/937371 [patent_app_country] => US [patent_app_date] => 2018-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6209 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15937371 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/937371
Methods for obtaining information from single cells within populations using DNA origami nanostructures without the need for single cell sorting Mar 26, 2018 Issued
Array ( [id] => 18117528 [patent_doc_number] => 11548909 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-10 [patent_title] => Methods of using nucleotide analogues [patent_app_type] => utility [patent_app_number] => 15/928562 [patent_app_country] => US [patent_app_date] => 2018-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 72 [patent_figures_cnt] => 89 [patent_no_of_words] => 31650 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15928562 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/928562
Methods of using nucleotide analogues Mar 21, 2018 Issued
Array ( [id] => 13316917 [patent_doc_number] => 20180209996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-26 [patent_title] => MARKER COMPOSITION COMPRISING S1P LIPID FOR PREDICTING RISK OF OSTEOPOROTIC FRACTURE AND OSTEOPOROSIS [patent_app_type] => utility [patent_app_number] => 15/927459 [patent_app_country] => US [patent_app_date] => 2018-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4620 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15927459 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/927459
MARKER COMPOSITION COMPRISING S1P LIPID FOR PREDICTING RISK OF OSTEOPOROTIC FRACTURE AND OSTEOPOROSIS Mar 20, 2018 Abandoned
Array ( [id] => 13329127 [patent_doc_number] => 20180216101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-02 [patent_title] => MICROBIAL STRAIN IMPROVEMENT BY A HTP GENOMIC ENGINEERING PLATFORM [patent_app_type] => utility [patent_app_number] => 15/923555 [patent_app_country] => US [patent_app_date] => 2018-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67009 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 338 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15923555 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/923555
Microbial strain improvement by a HTP genomic engineering platform Mar 15, 2018 Issued
Array ( [id] => 13428783 [patent_doc_number] => 20180265934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-20 [patent_title] => COINCIDENCE REPORTER GENE SYSTEM [patent_app_type] => utility [patent_app_number] => 15/916762 [patent_app_country] => US [patent_app_date] => 2018-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17287 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15916762 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/916762
COINCIDENCE REPORTER GENE SYSTEM Mar 8, 2018 Abandoned
Array ( [id] => 14732033 [patent_doc_number] => 10385407 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-20 [patent_title] => Method for screening induced pluripotent stem cells [patent_app_type] => utility [patent_app_number] => 15/909666 [patent_app_country] => US [patent_app_date] => 2018-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9803 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15909666 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/909666
Method for screening induced pluripotent stem cells Feb 28, 2018 Issued
Array ( [id] => 15541261 [patent_doc_number] => 10570397 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-25 [patent_title] => Reduction of lipase activity in product formulations [patent_app_type] => utility [patent_app_number] => 15/897290 [patent_app_country] => US [patent_app_date] => 2018-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15461 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15897290 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/897290
Reduction of lipase activity in product formulations Feb 14, 2018 Issued
Array ( [id] => 13343549 [patent_doc_number] => 20180223314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-09 [patent_title] => POTENT AND SHORT PROMOTER FOR EXPRESSION OF HETEROLOGOUS GENES [patent_app_type] => utility [patent_app_number] => 15/891986 [patent_app_country] => US [patent_app_date] => 2018-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24224 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15891986 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/891986
Potent and short promoter for expression of heterologous genes Feb 7, 2018 Issued
Array ( [id] => 18369311 [patent_doc_number] => 11649468 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-16 [patent_title] => Targeted integration into the PPP1R12C locus [patent_app_type] => utility [patent_app_number] => 15/880354 [patent_app_country] => US [patent_app_date] => 2018-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 22 [patent_no_of_words] => 18959 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15880354 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/880354
Targeted integration into the PPP1R12C locus Jan 24, 2018 Issued
Array ( [id] => 15294211 [patent_doc_number] => 20190390241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-26 [patent_title] => VIRAL RESISTANT CELLS AND CULTURE SYSTEMS [patent_app_type] => utility [patent_app_number] => 16/480588 [patent_app_country] => US [patent_app_date] => 2018-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17470 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480588 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/480588
VIRAL RESISTANT CELLS AND CULTURE SYSTEMS Jan 23, 2018 Abandoned
Array ( [id] => 15267983 [patent_doc_number] => 20190382725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-19 [patent_title] => SYSTEMS AND METHODS FOR IMMUNOMODULATION OF MUCOSAL-ASSOCIATED INVARIANT T CELLS [patent_app_type] => utility [patent_app_number] => 16/480273 [patent_app_country] => US [patent_app_date] => 2018-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15061 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -72 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480273 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/480273
Systems and methods for immunomodulation of mucosal-associated invariant T cells Jan 22, 2018 Issued
Menu